These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 2470129

  • 1. Structure and function of prostatic- and seminal vesicle-secreted proteins involved in the gelation and liquefaction of human semen.
    Lilja H.
    Scand J Clin Lab Invest Suppl; 1988; 191():13-20. PubMed ID: 2470129
    [Abstract] [Full Text] [Related]

  • 2. Seminal vesicle-secreted proteins and their reactions during gelation and liquefaction of human semen.
    Lilja H, Oldbring J, Rannevik G, Laurell CB.
    J Clin Invest; 1987 Aug; 80(2):281-5. PubMed ID: 3611349
    [Abstract] [Full Text] [Related]

  • 3. Characterization of prostate-specific antigen proteolytic activity on its major physiological substrate, the sperm motility inhibitor precursor/semenogelin I.
    Robert M, Gibbs BF, Jacobson E, Gagnon C.
    Biochemistry; 1997 Apr 01; 36(13):3811-9. PubMed ID: 9092810
    [Abstract] [Full Text] [Related]

  • 4. Distribution and tissue expression of semenogelin I and II in man as demonstrated by in situ hybridization and immunocytochemistry.
    Bjartell A, Malm J, Moller C, Gunnarsson M, Lundwall A, H Lilja.
    J Androl; 1996 Apr 01; 17(1):17-26. PubMed ID: 8833737
    [Abstract] [Full Text] [Related]

  • 5. The GPI-anchored CD52 antigen of the sperm surface interacts with semenogelin and participates in clot formation and liquefaction of human semen.
    Flori F, Ermini L, La Sala GB, Nicoli A, Capone A, Focarelli R, Rosati F, Giovampaola CD.
    Mol Reprod Dev; 2008 Feb 01; 75(2):326-35. PubMed ID: 17624925
    [Abstract] [Full Text] [Related]

  • 6. Dynamics of a human seminal vesicle specific protein.
    Flickinger CJ, Herr JC, McGee RS, Sigman M, Evans RJ, Sutherland WM, Summers TA, Spell DR, Conklin DJ.
    Andrologia; 1990 Feb 01; 22 Suppl 1():142-54. PubMed ID: 1720288
    [Abstract] [Full Text] [Related]

  • 7. Semenogelin I: a coagulum forming, multifunctional seminal vesicle protein.
    Robert M, Gagnon C.
    Cell Mol Life Sci; 1999 Jun 01; 55(6-7):944-60. PubMed ID: 10412373
    [Abstract] [Full Text] [Related]

  • 8. Cell biology of semenogelin.
    Lilja H.
    Andrologia; 1990 Jun 01; 22 Suppl 1():132-41. PubMed ID: 2132066
    [Abstract] [Full Text] [Related]

  • 9. [Advances in the study of Semenogelin I from human seminal vesicles].
    Su SF, Wang ZJ.
    Zhonghua Nan Ke Xue; 2009 Apr 01; 15(4):364-6. PubMed ID: 19472915
    [Abstract] [Full Text] [Related]

  • 10. Purification and characterization of the active precursor of a human sperm motility inhibitor secreted by the seminal vesicles: identity with semenogelin.
    Robert M, Gagnon C.
    Biol Reprod; 1996 Oct 01; 55(4):813-21. PubMed ID: 8879494
    [Abstract] [Full Text] [Related]

  • 11. Molecular cloning of epididymal and seminal vesicular transcripts encoding a semenogelin-related protein.
    Lilja H, Lundwall A.
    Proc Natl Acad Sci U S A; 1992 May 15; 89(10):4559-63. PubMed ID: 1584792
    [Abstract] [Full Text] [Related]

  • 12. A major secretory protein from rat seminal vesicle binds ejaculated spermatozoa.
    Manco G, Abrescia P.
    Gamete Res; 1988 Sep 15; 21(1):71-84. PubMed ID: 2906623
    [Abstract] [Full Text] [Related]

  • 13. Demonstration of the role of prostate-specific antigen in semen liquefaction by two-dimensional electrophoresis.
    Lee C, Keefer M, Zhao ZW, Kroes R, Berg L, Liu XX, Sensibar J.
    J Androl; 1989 Sep 15; 10(6):432-8. PubMed ID: 2482840
    [Abstract] [Full Text] [Related]

  • 14. Non-liquefaction of semen: a physiological therapeutic approach?
    Colpi GM, Balerna M, Campana A, Andò S.
    Acta Eur Fertil; 1983 Sep 15; 14(4):261-4. PubMed ID: 6673444
    [No Abstract] [Full Text] [Related]

  • 15. Effect of seminal plasma on motion characteristics of epididymal and ejaculated stallion spermatozoa during storage at 5 degrees C.
    Braun J, Torres-Boggino F, Hochi S, Oguri N.
    Dtsch Tierarztl Wochenschr; 1994 Aug 15; 101(8):319-22. PubMed ID: 7924976
    [Abstract] [Full Text] [Related]

  • 16. Functional implications of membrane modification with semenogelins for inhibition of sperm motility in humans.
    Yoshida K, Krasznai ZT, Krasznai Z, Yoshiike M, Kawano N, Yoshida M, Morisawa M, Tóth Z, Bazsáné ZK, Márián T, Iwamoto T.
    Cell Motil Cytoskeleton; 2009 Feb 15; 66(2):99-108. PubMed ID: 19089943
    [Abstract] [Full Text] [Related]

  • 17. Origin of a sperm motility inhibitor from boar seminal plasma.
    Iwamoto T, Tanaka H, Osada T, Shinagawa T, Osamura Y, Gagnon C.
    Mol Reprod Dev; 1993 Dec 15; 36(4):475-81. PubMed ID: 8305210
    [Abstract] [Full Text] [Related]

  • 18. Impaired secretory function of the prostate in men with oligo-asthenozoospermia.
    Ahlgren G, Rannevik G, Lilja H.
    J Androl; 1995 Dec 15; 16(6):491-8. PubMed ID: 8867597
    [Abstract] [Full Text] [Related]

  • 19. Sperm motility inhibitor from human seminal plasma: presence of a precursor molecule in seminal vesicle fluid and its molecular processing after ejaculation.
    Robert M, Gagnon C.
    Int J Androl; 1994 Oct 15; 17(5):232-40. PubMed ID: 7698848
    [Abstract] [Full Text] [Related]

  • 20. [Neurophysiological effects of seminal vesicles].
    Wang DC, Wang JQ.
    Zhonghua Nan Ke Xue; 2018 Apr 15; 24(4):360-363. PubMed ID: 30168959
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.